Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial — Stella

Home/Long COVID/

View on ClinicalTrials.gov

Recruiting

Back to Long COVID trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Centre hospitalier affilié universitaire régional, Trois-Rivières, Quebec

Key details

Sponsor

Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec

Enrollment target

~40 participants

Started

February 2026

Primary completion

February 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.